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Abstract
Objectives: Cardiopulmonary exercise testing (CPET) may predict which patients are at risk for
adverse outcomes after major abdominal surgery. The primary aim of this study was to determine
whether CPET variables are predicative of morbidity.
Methods: High-risk patients undergoing elective, one-stage, open hepatic resection were preopera-
tively assessed using CPET. Morbidity, as defined by the Postoperative Morbidity Survey (POMS), was
assessed on postoperative day 3.
Results: A total of 104 patients underwent preoperative CPET and were included in the analysis. Of
these, 73 patients (70.2%) experienced postoperative morbidity. Oxygen consumption at anaerobic
threshold ( _VO2 at AT, ml/kg/min) was the only CPET predictor of postoperative morbidity on multivari-
able analysis, with an area under the curve (AUC) of 0.66 [95% confidence interval (CI) 0.55–0.76]. In
patients requiring a major hepatic resection (three or more segments), a _VO2 at AT of <10.2 ml/kg/min
gave an AUC of 0.79 (95% CI 0.68–0.86) with 83.9% sensitivity and 52.0% specificity, 80.6% positive
predictive value and 62.5% negative predictive value.
Conclusions: The application of a cut-off value for _VO2 at AT of <10.2 ml/kg/min in patients undergo-
ing major hepatic resection may be useful for predicting which patients will experience morbidity.
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Introduction
Advances in hepatic resection surgery have enabled the safe
resection of up to 60% of functional liver parenchyma1 and
improved in-hospital mortality rates to <2%.2,3 However, the
substantial physiological insult of this major procedure is asso-
ciated with high rates of postoperative morbidity in the order
of 50–60%.4,5 The ability to identify patients at risk for postop-
erative morbidity can inform decision making and support the
allocation of resources, including those of postoperative critical
care.
Cardiopulmonary exercise testing (CPET) is a method of
assessing preoperative cardiopulmonary fitness which has been
used successfully to improve the accuracy of preoperative pre-
diction of postoperative complications and mortality.6–8 In
major abdominal surgery, lower oxygen consumption at anaer-
obic threshold ( _VO2 at AT, ml/kg/min) measured by CPET is
associated with increased postoperative morbidity and poorer
clinical outcomes.9–11 However, the role of CPET in predicting
morbidity in hepatic resection is unclear. The primary aim of
this study was to determine whether CPET-derived variables
were associated with short-term morbidity.
Materials and methods
This was a single-centre, prospective cohort study of consecu-
tive patients aged over 18 years who underwent CPET as part
of preoperative assessment for elective, one-stage, open hepatic
resection at the Royal Marsden National Health Service Foun-
dation Trust between May 2010 and April 2014. Patients con-
sidered to be at high risk were referred for CPET. These
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included patients aged >70 years, patients aged <70 years with
cardiorespiratory comorbidities and patients scheduled for
hepatic resection involving synchronous bowel resection or
vascular reconstruction or extensive biliary resection. The study
was approved by the local institutional review board.
Cardiopulmonary exercise testing
Cardiopulmonary exercise testing was performed and reported
by one of three consultant anaesthetists. Testing was conducted
using the standardised approach recommended by the Ameri-
can Thoracic Society and American College of Physicians.12
Cardiopulmonary exercise testing was conducted on an elec-
tromagnetically braked cycle ergometer (Ultima CardiO2
;
Medical Graphics Corp., St Paul, MN, USA) following resting
spirometry. Testing consisted of a 3-min rest period, 3 min of
freewheeling and then pedalling against a ramped resistance/
workload. The workload ramp gradient was determined using
an accepted standard technique based on a calculation using
predicted freewheel oxygen uptake ( _VO2), predicted _VO2 at
peak exercise, height and age.12,13 Testing was terminated at
the patient’s volition, if the patient became symptomatic or if
he or she was unable to maintain a cadence rate of 60 revolu-
tions per minute (rpm). A 5-min recovery period was applied
after the termination of testing.
Ventilation and gas exchange were measured using a meta-
bolic cart (Geratherm Respiratory GmbH, Love Medical Ltd,
Manchester, UK). Heart rate, full 12-lead electrocardiogram
(ECG), blood pressure and pulse oximetry were monitored
throughout CPET.
The CPET data were analysed using Cardioperfect 1.6.2.1105
[Welch Allyn (UK) Ltd, Aston Abbotts, UK] and MedGraphics
BreezeSuite 7.2.0.64SP7 (Medical Graphics Corp.) to derive the
following variables: _VO2 at AT (ml/kg/min); peak _VO2 (ml/kg/
min); ventilatory equivalents for carbon dioxide (CO2) at AT
(VECO2), and heart rate at AT (beats/min). The _VO2 peak was
defined as the mean of the highest exertional oxygen uptake
achieved over the last 30 s of maximal exercise. The AT was
determined using the V-slope method outlined by Wasser-
man.13 Values, where appropriate, were indexed to actual body
weight. Table S1 (online) provides further explanation of the
CPET variables. Results were routinely reviewed and reported
by two of the consultant anaesthetists to ensure the validity of
all CPET values derived.
Patient population
Baseline patient characteristics recorded for all patients
included age, sex, body mass index (kg/m2), American Society
of Anesthesiologists (ASA) score, World Health Organization
functional status score,14 preoperative chemotherapy, history of
smoking, type of liver resection determined according to the
number of segments resected (minor for less than three seg-
ments and major for three or more segments),15 reason for
liver resection and presence of comorbidities.
Outcome measures
Outcomes were recorded by data collection officers blinded
to CPET data and not directly involved in the study. Mor-
bidity was measured using the Postoperative Morbidity Sur-
vey (POMS)16 on postoperative day (PoD) 3. The POMS
classifies morbidities according to whether they refer to car-
diovascular, pulmonary, renal, gastrointestinal, neurological,
infectious or haematological occurrences, wound complica-
tions or pain.
The primary outcome was the presence of postoperative
morbidity defined as a POMS score of ≥1 on PoD 3. Compli-
cations were also classed according to the Clavien–Dindo sys-
tem of classification,17 but these data were not used in the
primary outcome analysis because poor performance on CPET
is associated with both postoperative medical and surgical
complications and thus it was considered to be more appropri-
ate to assess individual systems as per the POMS. Secondary
outcomes measures were length of stay (LoS) in hospital, LoS
in the critical care unit (CCU) and readmission to the CCU.
Perioperative management
All patients were admitted to hospital on the day of scheduled
surgery. Anaesthesia was provided by one of three consultant
anaesthetists and surgery performed by one of two consultant
hepatobiliary surgeons. The hepatic resection was performed
using the Cavitron Ultrasonic Surgical Aspirator (CUSA; Val-
leylab, Inc., Boulder, CO, USA) and argon beam coagulation.
For patients with malignant tumours, the transection plane
was first determined by intraoperative ultrasonography and the
resection phase was performed under low central venous pres-
sure conditions. There were no protocols for intraoperative
management, but patients deemed to be at high risk were
given additional cardiac output monitoring. The standard
method of postoperative pain management referred to a tho-
racic epidural, from which the patient was weaned before
PoD 3. Postoperative management included the routine admis-
sion of all patients to the CCU. A protocalized care package
that included early mobilization and commencement of enteral
nutrition was applied to all patients.
Statistical analysis
Continuous variables are reported as the mean  standard
deviation or median and interquartile range (IQR), depending
on their distribution. Categorical variables are reported as fre-
quencies with percentages. All statistical results are accompa-
nied by 95% confidence intervals (CIs). Non-parametric
receiver operating characteristic (ROC) curves were con-
structed for CPET variables associated with POMS-defined
morbidity on PoD 3 to assess their independent ability to dis-
criminate between patients with and without in-hospital post-
operative morbidity. Optimal cut-off points were obtained by
minimizing the distance between points on the ROC curve and
the upper left corner.
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Logistic regression analysis was used to assess the indepen-
dent and multivariable relationships between POMS-defined
postoperative morbidity on PoD 3 and predictive variables.
Audit data from the study institution indicated that approxi-
mately 70% of patients submitted to hepatic resection experi-
enced postoperative POMS-defined morbidity. Seven predictive
variables (limited to satisfy the ‘10 events per variable’ rule 18)
were thus identified as likely causal or predictive factors for a
multivariable logistic regression model: _VO2 at AT; _VO2 peak;
VECO2 at AT; heart rate at AT; extent of liver resection (minor
or major); gender, and age. A backward stepwise selection pro-
cedure was employed in order to identify a suitable multivari-
able model. The sensitivity of the selected model to variable
exclusion, the inclusion of non-selected variables and two-way
interactions was also assessed using the Akaike information cri-
terion (AIC). The Hosmer–Lemeshow goodness-of-fit test was
used to assess the adequacy of each logistic regression model.
For hospital LoS, Cox regression was used with the same
model selection as for the logistic regression analyses. Patients
who died were treated as censored for the purposes of analysis.
Categorical comparisons were conducted using the chi-
squared test or Fisher’s exact test depending on cell number.
Non-parametric comparisons were performed using the
Mann–Whitney U-test. Parametric comparisons were carried
out using Student’s t-test. All analyses were undertaken using
STATA Version 12.0 (StataCorp LP, College Station, TX, USA).
Results
A total of 218 patients were scheduled for hepatic resection
during the study period, of whom 116 (53.2%) underwent
CPET prior to surgery (Fig. 1). There were no complications
during the performance of CPET in these 116 patients,
although two patients were unable to obtain ATs during CPET
and were excluded from analysis. A further 10 patients were
also excluded because they did not undergo the intended
Figure 1 Flow of patients in the study. CPET, cardiopulmonary exercise testing
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surgery following CPET. Of these, one declined surgery, one
died before the planned operation date, four were deemed to
be unfit for surgery following a multidisciplinary team decision
process and four patients had unresectable disease and under-
went open-and-close surgery. In total, 104 patients (60 men
and 44 women) underwent CPET followed by the intended
hepatic resection and their data were included in the analysis.
Table 1 shows patient demographics and perioperative charac-
teristics. Two patients (1.9%) died within 30 days of hepatic
resection. The first patient death occurred on PoD 6 and was
caused by a myocardial infarction. The second patient death
occurred on PoD 12 and was caused by multi-organ failure
following an extended right hepatectomy. Table 2 shows a
summary of the CPET data measured for all 104 patients
included in the analysis.
Postoperative morbidity
Seventy-three patients (70.2%) experienced POMS-defined
morbidity on PoD 3. The CPET variables on univariate analy-
sis associated with postoperative morbidity were V̇O2 AT and
_VO2 peak (Table 3). For _VO2 at AT and the presence of
POMS-defined morbidity, the area under the curve (AUC) was
0.66 (95% CI 0.55–0.76; P = 0.026). The optimal cut-off point
was 10.2 ml/kg/min, giving sensitivity of 65.3% and specificity
of 58.2%, a positive predictive value (PPV) of 64.3% and a
negative predictive value (NPV) of 59.2% (Fig. S1, online).
The AUC for VO2 peak and POMS-defined morbidity was
0.60 (95% CI 0.51–0.71; P = 0.048). The optimal cut-off was
15.8 ml/kg/min, giving sensitivity of 69.1% and specificity of
50.0%, with a PPV of 67.9% and NPV of 52.1% (Fig. S2,
online).
The proportion of patients experiencing POMS-defined
morbidity was significantly higher in patients undergoing
major liver resection compared with those undergoing minor
liver resection [odds ratio (OR) 2.97 (95% CI 1.90–4.82) and
OR 0.41 (95% CI 0.20–0.69), respectively; P = 0.004].
Odds ratios for _VO2 at AT (OR 1.23, 95% CI 1.02–1.38) and
major hepatic resection (OR 2.98, 95% CI 1.97–4.84) were
used in a multivariable logistic regression model for predicting
postoperative morbidity. When major liver resection was com-
bined with a _VO2 at AT of <10.2 ml/kg/min, the ability of the
model to discriminate which patients would suffer from mor-
bidity had an AUC of 0.79 (95% CI 0.68–0.86), with sensitivity
of 83.9%, specificity of 52.0%, a PPV of 80.6% and an NPV of
62.5%, for morbidity on PoD 3 (Fig. 2).
Table 2 Summary of cardiopulmonary exercise testing (CPET)
outcomes in patients undergoing hepatic resection (n = 104)
CPET variable Median (IQR)
VO2 AT, ml/kg/min 10.5 (9.2–11.3)
VO2 peak, ml/kg/min 15.5 (12.8–17.6)
VECO2 AT 32.4 (29.1–37.2)
Workload AT, Watts 58 (28–74)
O2 pulse AT, ml/beat 7 (6.2–9.1)
Heart rate AT, beats/min 103 (98–111)
AT, anaerobic threshold; IQR, interquartile range.
Table 1 Preoperative demographics and postoperative outcomes
in patients submitted to cardiopulmonary exercise testing prior to
hepatic resection (n = 104)
Variable Value
Age, years, median (IQR) 65 (55–70)
Sex ratio (M:F) 60:44
BMI, kg/m2, median (IQR) 26.4 (24.2–29.5)
Liver disease, n (%)
Colorectal liver metastasis 82 (78.8%)
Hepatocellular carcinoma 8 (76.9%)
Non-colorectal liver metastasis 3 (2.9%)
Other 11 (10.6%)
ASA score, median (IQR) 2 (2–3)
WHO performance status, n (%)
WHO 0 45 (43.2%)
WHO 1 54 (51.9%)
WHO 2 4 (3.8%)
WHO 3 1 (1.0%)





Chronic renal impairment 7 (7.6%)
Liver cirrhosis 9 (8.7%)
Type of surgery, n (%)
Minor liver resection 65 (62.5%)
Major liver resection 39 (37.5%)
Operating surgeon ratio (A:B) 55:49
Postoperative morbidity, n (%)
POMS score ≥1 on PoD 3 73 (70.2%)
Dindo–Clavien any grade 70 (65.4%)
Dindo–Clavien Grade III+ 25 (24.0%)
Length of stay, days, median (IQR)
Hospital 9 (7–11)
CCU 2 (1–3)
Readmission to CCU, n (%) 14 (13.5%)
Inpatient mortality, n (%) 2 (1.9%)
ASA, American Society of Anesthesiologists; BMI, body mass index;
CCU, critical care unit; COPD, chronic obstructive pulmonary disease;
F, female; IDDM, insulin-dependent diabetes mellitus; IHD, ischaemic
heart disease; IQR, interquartile range; M, male; PoD, postoperative
day; POMS, Postoperative Morbidity Survey; WHO, World Health
Organization.
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There were no differences in frequencies of POMS-defined
morbidity (P = 0.584) or complications of severity of Clavien–
Dindo Grade III or higher (P = 0.238) between patients oper-
ated by the two operating surgeons, respectively. Seventy
patients (67.3%) experienced complications of any Clavien–
Dindo grade and 25 patients (24.0%) experienced complica-
tions of Clavien–Dindo Grade III or higher. Major hepatic
resection was the only predictive or causal variable associated
with complications of Clavien–Dindo Grade III or higher (OR
3.43, 95% CI 2.32–4.78; P = 0.001) (Table S2, online).
Hospital LoS, CCU LoS and critical readmission rates
Major hepatic resection, increasing age and decreasing _VO2 at
AT were independently associated with increased hospital LoS
(Table 4). Patients with a higher _VO2 AT had an increased
chance of early discharge [hazard ratio (HR) 1.37, 95% CI
1.13–1.58], whereas patients undergoing major hepatic resec-
tion had a decreased chance of early discharge (HR 0.48, 95%
CI 0.32–0.67). In the final Cox multivariable model, major
hepatic resection (HR 0.46, 95% CI 0.31–0.69) and a decreas-
ing _VO2 at AT (HR 1.34, 95% CI 1.11–1.52) were associated
with later discharge from hospital. Major hepatic resection was
also associated with a significantly longer CCU LoS (3 days
versus 1 day; P < 0.001) and a higher rate of readmission to
the CCU (OR 3.23, 95% CI 2.13–4.52). None of the CPET
variables studied were associated with CCU LoS or readmission
to the CCU.
Discussion
The findings of this study show that the only CPET variable
associated with postoperative morbidity in high-risk patients
undergoing hepatic resection is VO2 at AT. A VO2 at AT
threshold of <10.2 ml/kg/min is a predictor of POMS-defined
morbidity on PoD 3 in patients undergoing major hepatic
resection.
Morbidity following major surgery when measured by the
POMS most frequently occurs on PoD 316 and a score of ≥1 is
associated with worse clinical outcomes, including longer hos-
pital LoS.9–11 The VO2 at AT threshold derived in this study
may be useful for deciding which patients following major
hepatic resection will benefit from increased medical resources
such as postoperative critical care or critical care outreach ser-
vices. Although the model has good sensitivity of 83.9% and a
PPV of 80.6%, its NPV is 62.5%, which limits its use as a rule-
out test. As a result, a significant proportion of patients identi-
fied by this model as unlikely to develop morbidity will
develop it.
In this study, the moderate capacity of VO2 at AT in pre-
dicting morbidity is in keeping with the literature evaluating
Table 3 Relationships between predictive variables and a Postoperative Morbidity Survey score of ≥1 on postoperative day 3




_VO2 AT, ml/kg/min, median (IQR) 10.5 (9.2–11.3) 1.24 (1.03–1.40; 0.022) 1.23 (1.02–1.38; 0.029)
VO2 peak, ml/kg/min, median (IQR) 15.5 (12.8–17.6) 1.03 (1.01–1.06; 0.044)
VECO2 AT, ml/kg/min, median (IQR) 32.4 (29.1–37.2) 1.02 (0.95–1.07; 0.542)
Heart rate AT, beats/min, median (IQR) 103 (98–111) 1.06 (0.77–1.89; 0.820)
Age, years, median (IQR) 65 (55–70) 1.01 (0.95–1.07; 0.142)
Gender, male, n (%) 60 (57.7%) 0.97 (0.65–1.76; 0.773)
Hepatic resection, n (%)
Major 39 (37.5%) 2.97 (1.90–4.82; 0.004) 2.98 (1.97–4.84; 0.003)
Minor 65 (62.5%) 0.41 (0.20–0.69)a
a
Odds ratio estimates for reference category of minor hepatic resection.
95% CI, 95% confidence interval; AT, anaerobic threshold; IQR, interquartile range; OR, odds ratio.
Figure 2 Receiver operating characteristic curve for the
multivariable logistic model combining major liver resection and a
VO2 at anaerobic threshold (AT) of <10.15 ml/kg/min for predicting
Postoperative Morbidity Survey (POMS)-defined morbidity (area
under the curve 0.79, 95% confidence interval 0.69–0.86)
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CPET variables as risk prediction tools in major abdominal
surgery.11,12,19 Only two studies investigating the use of CPET
in predicting outcomes in liver resection surgery have been
published. Neither study identified _VO2 at AT or _VO2 peak as
predictors of postoperative morbidity. Dunne et al.20 prospec-
tively assessed 197 patients who underwent preoperative CPET
and found the only variable associated with postoperative
morbidity (measured using complications classified by Cla-
vien–Dindo grade) was heart rate at AT (OR 1.02, 95% CI
1.00–1.04). Similar to this study, a higher _VO2 at AT was asso-
ciated with a shorter time to discharge from hospital (HR 2.16,
95% CI 1.18–3.96) and the size of the hepatic resection was
the most important variable in predicting postoperative mor-
bidity. Junejo et al.’s5 evaluation of CPET in predicting out-
comes in hepatic resection surgery is more comparable with
this study in that it used a similar number of patients
(n = 108), applied CPET in patients considered to be at high
risk and used POMS scores to assess morbidity. Unlike this
study, Junejo et al.5 found VECO2 at AT to be the only CPET
variable independently associated with postoperative morbidity,
with an AUC of 0.65 (95% CI 0.53–0.77). A VECO2 at AT of
≥34.5 ml/kg/min was found to have specificity of 84% and
sensitivity of 47%, with a PPV of 76% and an NPV of 60%,
for POMS-defined morbidity.
The limitations of this study include the applicability of its
data to high-risk patients only, which was determined by the
study’s inclusion criteria. Additionally, although the size of the
study population is comparative with that in other CPET stud-
ies,5,21 it is small. This limited the number of predictive vari-
ables that could be studied in the multivariable analysis.
Finally, the fact that CPET data were available to clinicians
may have impacted on the perioperative management of
patients and thus affected outcomes. The main strength of the
study was that data collection was performed prospectively by
data collection officers blinded to CPET results using validated
measures of morbidity.
In conclusion, a _VO2 at AT of <10.2 ml/kg/min in patients
undergoing major hepatic resection surgery may serve as a use-
ful rule-in parameter for predicting which patients will experi-
ence postoperative morbidity.
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